Bayer is very keen to improve the sales of its drug Levitra...

The makers of the erectile dysfunction drug Levitra namely Bayer have been reorganizing their drugs business and have decided to setup a new Men's Healthcare section within the company.  What they have decided to do is group the 3 urology medications that they produce into one division. What this means is that the erectile dysfunction drug Levitra as well as a treatment called Testogel that is a testosterone replacement therapy and lastly another treatment called Nebido which is a testosterone deficiency medicine will be under one umbrella and in one division.

Bayer said that this will be very useful to doctors and healthcare professionals who will now be able to have a complete package of medication and treatment for men who suffer from erectile dysfunction. Testosterone can help improve the libido and sexual desire of some men and along with the Levitra drug can mean that a man can restore himself back to a healthy sexual function.

Along with all manufacturers of erectile dysfunction medication, Bayer is very keen to improve the sales of its drug Levitra.  In view of this it is setting up a three year research project for Levitra which is called REPEAT. The idea is that feedback from patients and their partners will be made available to doctors as well as Bayer in order to improve the way that they prescribe and promote the erectile dysfunction medication Levitra.

Despite the fact that Levitra is the least well known impotence drug it is as effective as Viagra and this has been proven by a number of clinical tests where men were asked for feedback on the use of an impotence drug not knowing whether it was in fact Levitra or Viagra. In some cases the men said that they actually had better results with the Levitra drug then they had with the Viagra drug.